The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Gel
Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Gel · BENZYL ALCOHOL 10 g/100mL; LIDOCAINE HYDROCHLORIDE 4 g/100mL · Gel · Topical · Clarion Brands LLC
NDC 69693-0003-03 · 1 mL in 1 BOTTLE, PLASTIC · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M017
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Gel (Gel)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Clarion Brands LLC | BENZYL ALCOHOL 10 g/100mL; LIDOCAINE HYDROCHLORIDE 4 g/100mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Gel — NDC 69693-0003-03," retrieved September 3, 2026, https://drugdashboards.com/drug/69693000303.
Free to cite with attribution — see how the data is put together.